Zhaowen Zhu
Zhaowen Zhu
Okänd anknytning
Verifierad e-postadress på uiowa.edu
Titel
Citeras av
Citeras av
År
High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma
ET Kimura, MN Nikiforova, Z Zhu, JA Knauf, YE Nikiforov, JA Fagin
Cancer research 63 (7), 1454-1457, 2003
16572003
BRAF Mutations in Thyroid Tumors Are Restricted to Papillary Carcinomas and Anaplastic or Poorly Differentiated Carcinomas Arising from Papillary Carcinomas
MN Nikiforova, ET Kimura, M Gandhi, PW Biddinger, JA Knauf, F Basolo, ...
The Journal of Clinical Endocrinology & Metabolism 88 (11), 5399-5404, 2003
11332003
Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules
YE Nikiforov, DL Steward, TM Robinson-Smith, BR Haugen, JP Klopper, ...
The Journal of Clinical Endocrinology & Metabolism 94 (6), 2092-2098, 2009
7352009
Correlation between genetic alterations and microscopic features, clinical manifestations, and prognostic characteristics of thyroid papillary carcinomas
AJ Adeniran, Z Zhu, M Gandhi, DL Steward, JP Fidler, TJ Giordano, ...
The American journal of surgical pathology 30 (2), 216-222, 2006
5502006
Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer
R Ciampi, JA Knauf, R Kerler, M Gandhi, Z Zhu, MN Nikiforova, HM Rabes, ...
The Journal of clinical investigation 115 (1), 94-101, 2005
4952005
Molecular Profile and Clinical-Pathologic Features of the Follicular Variant of Papillary Thyroid Carcinoma: An Unusually High Prevalence of ras Mutations
Z Zhu, M Gandhi, MN Nikiforova, AH Fischer, YE Nikiforov
American journal of clinical pathology 120 (1), 71-77, 2003
4532003
Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis
TJ Giordano, R Kuick, DG Thomas, DE Misek, M Vinco, D Sanders, Z Zhu, ...
Oncogene 24 (44), 6646-6656, 2005
3942005
Prevalence of RET/PTC Rearrangements in Thyroid Papillary Carcinomas: Effects of the Detection Methods and Genetic Heterogeneity
Z Zhu, R Ciampi, MN Nikiforova, M Gandhi, YE Nikiforov
The Journal of Clinical Endocrinology & Metabolism 91 (9), 3603-3610, 2006
2322006
Delineation, functional validation, and bioinformatic evaluation of gene expression in thyroid follicular carcinomas with the PAX8-PPARG translocation
TJ Giordano, AYM Au, R Kuick, DG Thomas, DR Rhodes, KG Wilhelm, ...
Clinical Cancer Research 12 (7), 1983-1993, 2006
1352006
Heme oxygenase‐1 suppresses hepatitis C virus replication and increases resistance of hepatocytes to oxidant injury
Z Zhu, AT Wilson, MM Mathahs, F Wen, KE Brown, BA Luxon, ...
Hepatology 48 (5), 1430-1439, 2008
1232008
Dose-Dependent Generation of RET/PTC in Human Thyroid Cells after in Vitro Exposure to γ-Radiation: A Model of Carcinogenic Chromosomal Rearrangement …
CM Caudill, Z Zhu, R Ciampi, JR Stringer, YE Nikiforov
The Journal of Clinical Endocrinology & Metabolism 90 (4), 2364-2369, 2005
1202005
Biliverdin inhibits hepatitis C virus nonstructural 3/4A protease activity: mechanism for the antiviral effects of heme oxygenase?
Z Zhu, AT Wilson, BA Luxon, KE Brown, MM Mathahs, S Bandyopadhyay, ...
Hepatology 52 (6), 1897-1905, 2010
702010
BRAF copy number gains in thyroid tumors detected by fluorescence in situ hybridization
R Ciampi, Z Zhu, YE Nikiforov
Endocrine pathology 16 (2), 99-105, 2005
462005
Heme and HO-1 inhibition of HCV, HBV, and HIV
WN Schmidt, MM Mathahs, Z Zhu
Frontiers in pharmacology 3, 129, 2012
402012
Hepatitis C virus core protein enhances Telomerase activity in Huh7 cells
Z Zhu, AT Wilson, K Gopalakrishna, KE Brown, BA Luxon, WN Schmidt
Journal of medical virology 82 (2), 239-248, 2010
262010
Restoration of type I interferon expression by heme and related tetrapyrroles through inhibition of NS3/4A protease
Z Zhu, MM Mathahs, WN Schmidt
The Journal of infectious diseases 208 (10), 1653-1663, 2013
52013
HCV Induces telomerase reverse transcriptase, increases its catalytic activity, and promotes caspase degradation in infected human hepatocytes
Z Zhu, H Tran, MM Mathahs, TO Moninger, WN Schmidt
PloS one 12 (1), e0166853, 2017
42017
BILIVERDIN AND HEME RESTORE TYPE I INTERFERON EXPRESSION IN CELLS EXPRESSING HCV NS3/4A PROTEASE: 365
Z Zhu, M Mathahs, W Schmidt
Hepatology 54 (4), 2011
22011
ANTIVIRAL EFFECTS OF HEME OXYGENASE-1: INHIBITION OF HCV NS3/4A PROTEASE BY BILIVERDIN AND ITS METABOLITES: 791
Z Zhu, Y Zhao, K Brown, B Luxon, W Schmidt
Hepatology 50, 2009
12009
Heme oxygenase-1 reaction products suppress hepatitis C virus replication in full length and non-structural replicon cell lines
Z Zhu, AT Wilson, K Brown, BA Luxon, WN Schmidt
Hepatology 48 (4), 1162A-1163A, 2008
12008
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20